HPM Posts Summary of H.R. 3962 Provisions Directly Affecting Drug and Device Manufacturers

By Alan M. Kirschenbaum & Kurt R. Karst –

Last Thursday we reported on the release by the House of H.R. 3962, the health care reform bill that will soon be considered on the House floor.  As we have done with other health care reform proposals, we have prepared a summary of the provisions of H.R. 3962 that are of direct interest to pharmaceutical and medical device manufacturers.  Our summary can be found here.  The full text of the bill can be found here.